Ashcraft & Gerel LLP The Victims' Rights Law Firm Washington, D.C. Maryland (Baltimore Landover Rockville) Virginia

Bausch And Lomb Contact Lens Solution, Renu With Moistureloc, Removed From Market -  Found to Cause Severe Eye Infections

BAUSCH AND LOMB CONTACT LENS SOLUTION, RENU WITH MOISTURELOC, REMOVED FROM MARKET - FOUND TO CAUSE SEVERE EYE INFECTIONS

We're sorry, but we are no longer accepting Renu claims.

[Introduction: If you or a loved one had injuries consisting of eye damage from an infection after using a Bausch & Lomb contact lens solution called Renu with Moistureloc, you may have a lawsuit that should be pursued. Although our lawyers who handle Renu with Moistureloc lawsuits are located in Maryland (MD), Virginia (VA) and Washington, D.C. (DC), our drug litigation and medical product liability lawsuits are national in scope, and our lawyers who handle these suits are prepared to file lawsuits and litigate Renu with Moistureloc cases across the country. Therefore, regardless of what state you're from, please fill out our inquiry form on this web site or email us so that Ashcraft & Gerel, LLP can have a lawyer familiar with the litigation over Renu with Moistureloc contact you to discuss your claim and the potential for a lawsuit.]

ReNu with MoistureLoc contact lense solution has been associated with a rare fungal infection called fusarium keratitis. Fusarium keratitis causes severe eye irritation, may require corneal transplant and causes blindness if left untreated. Symptoms of fungal eye infection include blurry vision, eye pain, eye redness, sensitivity to light and discharge. 

ReNu with MoistureLoc contact lens solution, was being manufactured in a Greenville, South Carolina plant, by the Rochester, New York based Bausch and Lomb, until the product was voluntarily withdrawn from the market in the United States on April 13, 2006. 

On March 8, 2006, before the product was removed from the U.S. stores, the Centers for Disease Control and Prevention (CDC) received a report regarding three patients with contact lens-associated fusarium keratitis occurring within three months of the report. Initial contact with several corneal disease specialty centers in the United States revealed that other centers also had seen recent increases in fusarium keratitis. The CDC began an investigation of the Fusarium keratitis outbreak. As of May 2006, there were 130 confirmed cases of Fusarium keratitis. Over 60% of the people with confirmed fusarium keratitis had used ReNu with MoistureLoc, a Bausch & Lomb contact lens solution. 37 of the cases resulted in cornea transplant surgery. 

Finally, on May 15, 2006, Bausch and Lomb announced its decision to permanently remove all ReNu with MoistureLoc products worldwide. According to Bausch & Lomb, "unique characteristics of the formulation of the ReNu with MoistureLoc product in certain unusual circumstances can increase the risk of fusarium infection." 

The U.S. Food and Drug Administration (FDA) and the Center for Disease Control (CDC) have alerted health care professionals and their patients who wear soft contact lenses to an increasing number of reports of rare but serious fungal infections in the eye that can cause permanent blindness. Some patients have reported a significant loss of vision, resulting in the need for a corneal transplant. 

The FDA and CDC are also advising consumers to take precautions to prevent contamination of the lenses and the products used to maintain them. These preventive practices include: 

• Wash hands with soap and water, and dry (lint-free method) before handling lenses. 
• Wear and replace lenses according to the schedule prescribed by the doctor. 
• Follow the specific lense cleaning and storage guidelines from the doctor and the solution manufacturer.
• Keep the contact lens case clean and replace every 3-6 months. 
• Remove the lenses and consult your doctor immediately if you experience symptoms such as redness, pain, tearing, increased light sensitivity, blurry vision, discharge or swelling.
• In addition, regardless of which cleaning/disinfecting solution used, wearers may want to consider performing a "rub and rinse" lens cleaning method, rather than a no-rub method, in order to minimize the number of germs and reduce the chances of infection. 

In addition, the FDA and CDC are urgently advising consumers to consult their doctors immediately if they experience symptoms such as redness, pain, tearing, increased light sensitivity, blurry vision, discharge or swelling. 

If you think you or a loved one may have suffered an injury or damages as a result of using Bausch and Lomb brand Renu MoistureLoc contact lense solution, you owe it to yourself to speak to an experienced product, drug or pharmaceutical attorney to see if you have a case and to discuss the possibility of bringing a lawsuit to recover for your damages and injuries. The attorney will be able to ascertain if you have a claim for which a lawsuit can be pursued and whether the case and lawsuit can be brought to a successful settlement, verdict, award or other recovery, and the experienced lawyer will be able to advise you on any deadlines for bringing your legal claim for damages. Please contact the law firm of Ashcraft and Gerel, LLP to discuss your case with an experienced drug, pharmaceutical or medical product liability lawyer in our Drug Litigation Department. 

The lawyers at Ashcraft and Gerel, LLP have been leaders in pursuing lawsuits involving unsafe drugs and medical products. Our attorneys have successfully brought about verdicts, settlements, awards or other recoveries in lawsuits on behalf of clients who have been injured by Fen-Phen, Rezulin, Propulsid, Phenylpropanolamine (PPA), Baycol, breast implants and AIDS tainted blood. We have a toll free number to reach an attorney to answer your questions with regard to your specific case. That number is 1-800-829-7037. Please ask to speak to Robert Samet, and he will place you in touch with one of our drug litigation lawyers. If you would prefer, please feel free to e-mail us or complete the help inquiry form on this web site. Please be sure to include your name, address, telephone number (if you wish to be called), email address and the exact nature of your question, so that our lawyer can provide you with the specific information you seek.

[ Return to Homepage ]  [ Help ]  [ Learn About Ashcraft & Gerel ]  [ See Our Offices and Attorneys ]  [ Email Us ]  [ Links ] [Resources]  [AG Friends & Associates]  [ Contingent Fees in Personal Injury Litigation ]  [ Workers' Compensation ]  [Maryland Workers' Compensation]  [District of Columbia Workers' Compensation]  [Virginia Workers' Compensation]  [ Product Liability Law ]  [ Cerebral Palsy ]  [ Medical Malpractice ]  [ Automobile Accident Litigation ]  [Maryland, Virginia and D.C. Injuries and Accidents] [ Birth Injury Litigation ]  [ Social Security Disability ]  [ Fen Phen Litigation ]  [ Asbestos Litigation ]  [ Toxic Tort Litigation ]  [ Breast Implant Litigation ]  [ Whistle Blower Litigation ]  [ Construction Litigation ]  [ Railroad Worker (FELA) Litigation ]  [ Propulsid Litigation ]  [ PPA Litigation ]  [ Nursing Home Malpractice ]  [ Sulzer Defective Hip Implants ]  [ Defense Base Act Claims ]  [ Baycol Claims ]  [ Other Hip Implant Claims ]  [ Thimerosal Mercury Poisoning Autism Claims ]  [ Olympus Bronchoscope Claims ]  [ Serzone Liver Damage Claims ]  [Ephedra Claims] [Crestor Claims] [ Meridia Claims ]  [ Lead Paint Claims ]  [ Vioxx Claims ]  [Celebrex Claims]  [Bextra Claims]  [Ortho Evra Claims]